News

BIOPIX-T is thrilled to announce the successful evaluation of the ResTick project, led by Kotsyfakis Michail and the Foundation for Research and Technology – Hellas (FORTH) where we proudly serve as a partner in this transformative research consortium! ResTick focuses on addressing the urgent challenges posed by ticks as disease vectors, particularly in combating the […]

🎉 Today we celebrate BIOPIX-T’s 5th Birthday! 🎉 Over the past five years, we have achieved incredible milestones: ✅ Expanded our sales to 15 countries worldwide ✅ Brought five innovative products to market ✅ Cemented our presence in the global point-of-care market ✅ And we’re gearing up to unveil groundbreaking new products in 2025! This […]

#Verticilium #dahliae is the most important wilt #pathogen of #olive #trees with a broad host range causing devastating diseases currently without any effective chemical control. Traditional detection methodologies are based on symptoms-observation or lab-detection using time consuming culturing or molecular techniques. BIOPIX-T’s #PEBBLE can be used as a field-deployable #portable #device for the real-time #detection […]

BIOPIX DNA TECHNOLOGY S.A. optimized Universal Mastermix contains all the required #reagents for the performance of real-time quantitative colorimetric #loop-meditated #isothermal #amplification #LAMP analysis of #DNA or #RNA samples. Only primers and the template for the target should be added. The Universal Mastermix is #open #access and #easily #customizable to suit your #diagnostic and #research […]

BIOPIX DNA TECHNOLOGY S.A. is delighted to partner with the Institute of Molecular Biology and Biotechnology (IMBB)-FORTH, a pioneer in the research of #infectious #diseases and #biomedical #technologies. IMBB will coordinate the creation of a new #Center of #Excellence (#DxHub) to promote #innovative solutions for the #detection of infectious diseases. A competitive grant from the […]

On August 20, 1897, Sir Ronald Ross found the #malaria parasite in the stomach of a female #Anopheles#mosquito, providing the first evidence that mosquitoes transmit malaria between humans. To commemorate this moment in history, World Mosquito Day (WMD) was founded. Each year, WMD presents us with an opportunity to raise awareness of the dangers posed […]

Alexandros Tsichlakis and Marina Ventouratou from BIOPIX DNA TECHNOLOGY S.A., a UniHealth EU partner were thrilled to participate in #EIT HEALTH Challenge in #Nantes, France and present the groundbreaking technology of their company. The scientific approach of BIOPIX DNA TECHNOLOGY S.A. could revolutionize the viruses testing, such as #STI (sexually transmitted infections), control and improve […]

Are you ready to revolutionize water monitoring? We sure are! Biopix-T is thrilled to announce its participation in the groundbreaking AquaBioSens project, where innovation meets environmental sustainability head-on. At AquaBioSens, we’re not just about monitoring water; we’re about making a real difference. Our project is all about implementing end-user-led design choices, ensuring that the novel […]

BIOPIX DNA TECHNOLOGY S.A. is excited to announce the launch of our latest product, the Universal Mastermix (CAT#000054), designed for Research Use Only. We are excited to announce the launch of our latest product, the Universal Mastermix (CAT#000054), designed for Research Use Only. This innovative Mastermix contains all the necessary reagents (excluding primers and DNA/RNA […]

✨ After a successful 2-day kick-off meeting in Heraklion, Crete, UniHealth partners are excited to start the implementation of the project. 🎯 UniHealth aims to develop accessible diagnostic tools. In the 36 months of the project, we intend to develop and deliver IVDR certified devices and molecular assays for emerging pathogens detection at the point-of-care. […]

Biopix-T was registered in the General Commercial Register of Greece (G.E.MH.) as a new joint-stock company under the name “BIOPIX DNA TECHNOLOGY S.A. and the distinctive title “BIOPIX-T”, which came from a conversion of Private Capital Company with the name “BIOPIX DNA TECHNOLOGY I.K.E.”  The statute of the new joint-stock company was also approved.

BIOPIX DNA TECHNOLOGY P.C. is pleased to announce a strategic distribution agreement with Kiara MedTech (Pty) Ltd for #southafrica & the sub-Saharan region, a distinguished name with a rich legacy in the #medtech sector. This collaboration represents a significant milestone in BIOPIX DNA TECHNOLOGY P.C.‘s mission to expand its market presence and provide cutting-edge solutions to […]

BIOPIX DNA TECHNOLOGY P.C. is pleased to announce a strategic distribution agreement with metabion for Germany & Austria, a distinguished name with a rich legacy in the IVD sector, being a globally leading supplier of Custom Nucleic Acids renowned for its focus on reliable supplies of consistently high-quality products and services. This collaboration represents a […]

Biopix-T has the support of Seedblink as well as co-investors Metavallon and 11VC in its new funding round. Seedblink is leading the funding landscape and the future of MedTech in the post-pandemic era. #StartupFunding #AngelInvesting #HealthTech #MedTech

From all of us at BIOPIX-T, we very much hope you have a Happy, Healthy and Successful New Year 2023!!!
We are about to launch a public bridge financing round in the coming weeks, followed by a full Series A round within the next two years. This bridge round will be funded by a combination of institutional investors who have already committed the majority of the necessary funds and a public crowdfunding campaign. All information about the terms and our future plans can be found by following this link: https://investors.seedblink.com/landing/2817c463e2c5f9c6 .

We are pleased to announce that BIOPIX-T is participating as a design and commercialization partner, in a grant that was awarded to a consortium of 12 esteemed research institutions and companies, with the aim to develop a point-of-care device for the early detection of Sepsis.

We are super-excited to announce that we have been selected as a winner of the 2021-2022 Tech Tour South East Europe Program after 2 rounds of intensive and competitive pitching sessions in Athens in May and online in June!

Another important milestone achieved! Our declaration of conformity as per IVDR, for the PEBBLE qcLAMP Platform, was today approved by the Greek Organization for Medicines! We are one of the first companies in Greece to achieve the IVDR compliance for one of its products! Congratulations to all the BIOPIXers whose hard work and dedication led to this achievement!!!

Finally, the long-awaited research paper detailing the work that was done developing IRIS – the predecessor of PEBBLE – has been published! https://www.nature.com/articles/s41598-022-06632-7 Congratulations to all researchers who contributed to this work but especially to our very own Dr. George Papadakis, Dr. Alexandros Pantazis, Mr. Nikolaos Fikas and Mrs. Stella Chatziioannidou who continue to develop […]

What a rewarding week the past week has been! Our team visited our partner Kiara Health in South Africa to complete the technology transfer for the production of the PEBBLE qcLAMP Platform and the COV19 qcLAMP kit!

At BIOPIX-T we are pleased to announce that the portable molecular diagnostic platform “PEBBLE” and its compatible diagnostic test for the detection of Coronavirus are now commercially available! The “PEBBLE qcLAMP Platform“, as its full name is, is the first Greek portable molecular diagnostic device based on LAMP technology (Isothermal PCR), which can be used at the Point-of-Care. It is notified to […]

BIOPIX-T (www.biopix-t.com ) is pleased to announce that its information security management system (ISMS) has been certified as per ISO/IEC 27001:2013 by DQS Hellas. Moreover, BIOPIX-T successfully audited for the extension of the scope of its ISO 13485:2016, also by DQS Hellas, to additionally include the “Technical Support” and also cover its new manufacturing premises. Our new certification as per ISO/IEC 27001:2013 confirms […]

After the initial investment from Metavallon.vc, we are exited to be also included in the portfolio of Eleven Ventures, further broadening the institutional support we receive and our geographical footprint! On the investment in BIOPIX-T Valeri Petrov, Partner at Eleven Ventures explains: “BIOPIX-T is our first investment in Greece and the company fits perfectly in one of our […]

BIOPIX-T (www.biopix-t.com ) is pleased to announce that its quality management system (QMS) has been successfully certified as per ISO 13485:2016 requirements by DQS Hellas, with scope “Design and Development, Production, Storage and Distribution of nucleic acid amplification kits (COV19 qc LAMP kit and Flu A qc LAMP kit) and instruments (Pebble qc LAMP platform)”.  Our ISO 13485:2016 certification serves our mission to offer safe portable In-Vitro diagnostic medical devices […]

BIOPIX-T was included in the EU startups list of the 10 promising startups from Greece to watch in 2021! We are among the 10 ‘up and coming’ local startups making a name for themselves, which were founded in the last 1-3 years, show promising signs, landed funding in the last year and are growing their teams […]

It is the policy of BIOPIX-T to develop, manufacture and market safe and effective products to applicable specifications that meet national and International Standards and Regulatory Requirements […]

On the 21st of October 2020, the Institute of Molecular Biology and Biotechnology (IMBB) initiated the implementation of a Research Project/Programme aiming at the molecular detection of the SARS-CoV-2 virus in samples coming from volunteers-employees who show no symptoms of an active infection. The target of the research programme is to act as an additional […]

BIOPIX-T (www.biopix-t.com ) is pleased to announce that a consortium of eight partners in which it participated, has been awarded EU funding (€2.4M) under the emergency call H2020-SC1-PHE-CORONAVIRUS-2020-2. The aim of the proposal, entitled “Market Release of a Portable Device for COVID-19 at the Point-of-Care; a Global Diagnostics Approach” with the acronym “IRIS-COV”, is the immediate development, certification and release of BIOPIX-T ‘s novel diagnostic platform, IRIS, to carry out a combined test for SARS-CoV–2 and Influenza A.   In addition to BIOPIX-T (medical device […]

BIOPIX-T was one of the 5 winners, out of 138 teams that participated in the 7th John and Mary Pappajohn Business Plan Competition, organised by the Entrepreneurship Hub at Anatolia College of Thessaloniki! We would like to thank the organisers for an excellent event, despite the pandemic related constraints, and the judges for believing in […]

BIOPIX-T is pleased to announce that it has been accepted as a member of the Hellenic Biocluster. Through the networking and collaborations that this membership will facilitate, we expect to accelerate our market entry both in Greece and abroad. We would like to thank the management board of HBio for recognizing our technology and our commercial […]

We are happy to announce today the official registration of our company! BIOPIX-T aims to revolutionize molecular diagnostics at the Point-Of-Care and Home-Testing environments on a global scale. BIOPIX DNA TECHNOLOGY P.C. is a Spin-Off company from the Institute Of Molecular Biology and Biotechnology (IMBB) at the Foundation of Research and Technology Hellas (FORTH). As a project under the umbrella […]